Phase 4CompletedINTERVENTIONAL
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
ClinicalTrials.gov · NCT02941367 · Registry updated: 2022-04-25
- Condition / research focus
- Diabetes Mellitus, Type 2
- Sponsor
- Sanofi
- Countries with listed sites
- India · Israel · Kuwait · Turkey (Türkiye)
- Registry dates and results
- Start: 2017-02-23. Completion: 2017-08-04 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Lixisenatide (AVE0010) (drug) — also listed as: Lyxumia
- Sulfonylurea (drug)
- metformin (drug)
- basal insulin (drug)
Where the study takes place — 16 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Investigational Site Number 356005
Ahmedabad, India
Site recruitment: Not reported - Investigational Site Number 356002
Bangalore, India
Site recruitment: Not reported - Investigational Site Number 356015
Bangalore, India
Site recruitment: Not reported - Investigational Site Number 356008
Bangalore, India
Site recruitment: Not reported - Investigational Site Number 356009
Hyderabad, India
Site recruitment: Not reported - Investigational Site Number 356018
Hyderabad, India
Site recruitment: Not reported - Investigational Site Number 356010
Hyderabad, India
Site recruitment: Not reported - Investigational Site Number 356003
Hyderabad, India
Site recruitment: Not reported - Investigational Site Number 356007
Jaipur, India
Site recruitment: Not reported - Investigational Site Number 356019
Madurai, India
Site recruitment: Not reported - Investigational Site Number 356014
Mumbai, India
Site recruitment: Not reported - Investigational Site Number 356022
Nagpur, India
Site recruitment: Not reported - Investigational Site Number 376001
Haifa, Israel
Site recruitment: Not reported - Investigational Site Number 376002
Safed, Israel
Site recruitment: Not reported - Investigational Site Number 414001
Kuwait City, Kuwait
Site recruitment: Not reported - Investigational Site Number 792002
Zonguldak, Turkey (Türkiye)
Site recruitment: Not reported